HP and Crospon, a medical device developer based in Galway, Ireland, has announced they have entered a licensing agreement for a drug delivery platform that enables painless, controlled release of one or more drugs in a single patch applied to the skin.

HP and Crospon, a medical device developer based in Galway, Ireland, today announced they have entered a licensing agreement for a drug delivery platform that enables painless, controlled release of one or more drugs in a single patch applied to the skin.

Challenging a basic tenet of the semiconductor industry, researchers at Hewlett-Packard have demonstrated a technology that could replace the transistor as the fundamental building block of all computers.